Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Phidea and Marvin Research complete merger
The combined company will also continue to operate its offices in Madrid, Spain providing drug development services to companies in need of a single source for clinical research
The combined company will also continue to operate its offices in Madrid, Spain providing drug development services to companies in need of a single source for clinical research
RoACTEMRA, in combination with methotrexate (MTX), is indicated for the treatment of adult patients with moderate to severe rheumatoid arthritis (RA) who have either responded inadequately to, or
According to the company, the malaria drug Artemisinin is scheduled for a third-quarter launch in 2009, and HIV/AIDS pharmaceuticals are in process. Mulugetta Bezzabeh, CEO of Rx for
In this newly created position, Ms Doudna will oversee the departments of protein chemistry and structural biology. Ms Doudna will be a member of the small molecule drug
The companies intend to provide a highly integrated platform for structure-based drug discovery with one stop shop for structure-guided discovery, chemistry, biology and structural biology capabilities. This arrangement
According to the company, Mr Roche, a beauty care and retail sales and marketing expert with more than 25 years of consumer packaged goods experience, now oversees all
At Abraxis Health, Dr Ploeg will be responsible for building and integrating the company’s evidenced-based medicine capabilities, drug-discovery efforts and external partnerships that will serve as the foundation
The company plans to appeal the order, which was issued in response to Eon’s motion for summary judgment without the benefit of a hearing. Furthermore, the order is
After analyzing the data from the three-month preclinical safety program, the company has decided to discontinue the diabetes program and not pursue further regulatory submissions for this indication.
This agreement secures a cost efficient long-term development and manufacturing plan for Athera, including possible future large volume commercial production. Annexin A5 is a biotechnology product produced using